 |
|
Antihypertensives and the Risk of Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas
Ronald I. Shorr, MD, MS;
Wayne A. Ray, PhD;
James R. Daugherty, MS;
Marie R. Griffin, MD, MPH
JAMA. 1997;278(1):40-43.
Abstract
| |
Context.
—β-Blockers and angiotensin-converting enzyme (ACE) inhibitors are effective antihypertensive agents for patients with diabetes mellitus. However, β-blockers attenuate some components of the autonomic response to hypoglycemia and could increase the risk of hypoglycemia. ACE inhibitors may increase insulin sensitivity and predispose users to hypoglycemia.
Objective.
—To determine whether use of cardioselective β-blockers, nonselective β-blockers, ACE inhibitors, thiazide diuretics, calcium channel blockers, or other antihypertensive drugs alters the risk of developing serious hypoglycemia among older persons prescribed insulin or sulfonylureas.
Design.
—Retrospective cohort study.
Setting.
—Tennessee Medicaid Program.
Patients.
—A total of 13 559 elderly (mean age, 78±7 years) Medicaid enrollees, who were prescribed insulin (n=5171, 38%) or sulfonylureas (n=8368, 62%) from 1985 through 1989. These enrollees contributed a total of 33107 person-years of insulin or sulfonylurea use for follow-up.
Measurements.
—Hospitalization, emergency department admission, or death associated with hypoglycemic symptoms and a concomitant blood glucose determination of less than 2.8 mmol/L (50 mg/dL).
Results.
—We identified 598 persons with an episode of serious hypoglycemia during the study period. The rate of serious hypoglycemia was 2.01 per 100 person-years among those who were not prescribed antihypertensives. Crude rates of serious hypoglycemia were highest among users of ACE inhibitors (2.47 per 100 person-years) and lowest among users of cardioselective β-blockers (1.23 per 100 person-years). However, when we controlled for demographic characteristics and markers of comorbidity, there was no statistically significant increase or decrease in risk of serious hypoglycemia among users of any class of antihypertensive agents compared with nonusers of antihypertensive drugs. Using nonselective β-blockers as the reference group, each of these agents was associated with a lower, but not statistically significant, risk of hypoglycemia.
Conclusions.
—In this population, specific antihypertensive drug therapy had little impact on the risk of hypoglycemia in older diabetic patients. Therapy should be chosen based on other considerations of safety and effectiveness.
Author Affiliations
From the Department of Preventive Medicine, University of Tennessee—Memphis College of Medicine and Department of Medical Education, Methodist Hospitals of Memphis (Dr Shorr); and the Division of Pharmacoepidemiology, Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tenn (Drs Ray and Griffin and Mr Daugherty).
Footnotes
Reprints: Ronald I. Shorr, MD, MS, Department of Medical Education, Methodist Hospitals of Memphis, 1265 Union Ave, Memphis, TN 38104.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Reexamining Misconceptions About {beta}-Blockers in Patients With Diabetes
McGill
Clin. Diabetes 2009;27:36-46.
ABSTRACT
| FULL TEXT
Hospitalization and Discharge Education of Emergency Department Patients With Hypoglycemia
Ginde et al.
The Diabetes Educator 2008;34:683-691.
ABSTRACT
| FULL TEXT
Treating Elderly People with Diabetes and Stages 3 and 4 Chronic Kidney Disease
Abaterusso et al.
CJASN 2008;3:1185-1194.
ABSTRACT
| FULL TEXT
Diabetes, left ventricular systolic dysfunction, and chronic heart failure
MacDonald et al.
Eur Heart J 2008;29:1224-1240.
ABSTRACT
| FULL TEXT
Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients With Diabetes
Winkelmayer et al.
Diabetes Care 2006;29:2210-2217.
ABSTRACT
| FULL TEXT
Hypoglycemia Not Likely an Issue With Beta-Blockers
DOC News 2006;3:5-5.
FULL TEXT
Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes
Gilbert et al.
CJASN 2006;1:193-208.
ABSTRACT
| FULL TEXT
Pharmacological Agents That Directly Modulate Insulin Secretion
Doyle and Egan
Pharmacol. Rev. 2003;55:105-131.
ABSTRACT
| FULL TEXT
Common Drug Pathways and Interactions
Kroner
Diabetes Spectr. 2002;15:249-255.
ABSTRACT
| FULL TEXT
Baseline Characteristics of the Diabetic Participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Barzilay et al.
Diabetes Care 2001;24:654-658.
ABSTRACT
| FULL TEXT
Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients: Results from the national cooperative cardiovascular project
Chen et al.
J Am Coll Cardiol 1999;34:1388-1394.
ABSTRACT
| FULL TEXT
The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Arch Intern Med 1997;157:2413-2446.
ABSTRACT
Risk of Hypoglycemia With Antihypertensive Medication
Suissa and Garbe
JAMA 1997;278:1570-1570.
ABSTRACT
Risk of Hypoglycemia With Antihypertensive Medication
Gambassi et al.
JAMA 1997;278:1569-1570.
ABSTRACT
ANTIHYPERTENSIVE THERAPIES SAFE FOR DIABETICS
JWatch General 1997;1997:3-3.
FULL TEXT
|
